# The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients

> **NCT01510509** · PHASE4 · UNKNOWN · sponsor: **Hospital Universitario Infanta Cristina**

## Conditions studied

- Diabetes Mellitus
- Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** Titanium bare metal stent (Titan2®)
- **DEVICE:** Everolimus Drug Eluting Stent (Xience-V®)

## Key facts

- **NCT ID:** NCT01510509
- **Lead sponsor:** Hospital Universitario Infanta Cristina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01510509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01510509, "The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01510509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*